News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Obecure Completes Patient Enrollment for Phase II Obesity Trial



4/11/2007 12:35:51 PM

RAMAT GAN, Israel--(BUSINESS WIRE)--Obecure has completed enrollment of patients for its Phase II clinical trial to evaluate the efficacy of the company’s OBE101 drug candidate for weight loss in obese patients. The double-blinded, placebo-controlled dose-ranging study is being conducted at 20 medical sites across the U.S.

Read at BioSpace.com


comments powered by Disqus
Obecure
 
 
Obesity

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES